Skip to main content

Abstract

Periventricular heterotopia (PH) is a disorder of neuronal migration. Previous clinical reports of PH have largely focused on the seizure-related and neurodevelopmental consequences of this condition. The authors report on four unrelated individuals with PH, with particular emphasis on their behavioral and psychiatric morbidity. A review of the literature suggests that neuropsychiatric presentations are an underrecognized consequence of PH. Clinicians need to be alert to psychiatric complications associated with PH and related disorders of neuronal migration.
Periventricular (or subependymal) heterotopia (PH) is a malformation of cortical development caused when clusters of neurons fail to migrate from the ventricular zone to the cerebral cortex, resulting in ectopic nodules of gray matter adjacent to the lateral ventricles. The etiology of PH is heterogeneous. Mutations in the X-linked FLNA gene are found in around 54% of female patients with classical bilateral PH.1 PH has also been described in patients with rare mutations in autosomal genes and several microdeletion syndromes.2 There is a preponderance of females with X-linked PH, as early lethality is common in males. Although the commonest presentation of X-linked PH is a focal seizure disorder, a variety of other neurological manifestations have been described, including dyslexia, mild intellectual disability (ID), and stroke.35 In addition to the high frequency of reading impairment, neuropsychological testing has also identified impairments in processing speed and executive functioning in patients with PH.3
There have been occasional reports of PH in patients with a range of neuropsychiatric disorders, including schizophrenia, depression, anxiety, and autism.69 Here we report on four patients with neuropsychiatric presentations associated with PH, two of whom had a mutation in FLNA. We go on to review the literature linking PH to neuropsychiatric disease. Our findings indicate that PH predisposes to a broad range of neuropsychiatric conditions and that this association is not specific to individuals with mutations at the FLNA locus.

Patient #1

This 22-year-old woman presented with intellectual disability (ID), an autism spectrum disorder (ASD) and a rapid-cycling mood disorder. The patient had no speech before the age of 3. In school, she attended a special-needs class because of numeracy and reading problems. At 9, she had suspected absence seizures. An MRI brain scan demonstrated extensive bilateral PH (Figure 1 [A]). The PH was near-contiguous in the bodies and anterior horns of both lateral ventricles, with nodules also present in the posterior and temporal horns bilaterally. Significant behavior problems began in adolescence; these included mood swings, anxiety, impulsiveness, irritability, and confrontational behavior. She was diagnosed with mild ID (IQ 61) and an ASD. She moved between several residential placements, often developing inappropriately intense attachments to staff members. She struggled with social interactions and had poor comprehension of social cues. Her behavior deteriorated perimenstrually; she would experience paranoid ideation, acute mood changes, sleep disturbance, nightmares, self-harming, and would become violent. Several sedative, antipsychotic, and antiepileptic medications were tried, but not tolerated. At 21, the patient spent several months as a psychiatric inpatient before being moved to a specialist nursing home. Sequencing of her FLNA gene found a novel missense mutation, c.331C>G, which predicted the substitution of a conserved residue in the protein (p.Leu111Val). Parental testing revealed that her mother was mosaic for the same mutation.
FIGURE 1. Axial T2-Weighted Brain MRI Scans of the Four Reported Patients
The scans demonstrate bilateral periventricular heterotopia (PH; white arrows). In patients 1 and 2 [A], [B], the PH was near-contiguous. Patients 3 and 4 [C], [D], had multiple discrete nodules. The lateral ventricles of Patient 3 were noted to be prominent.

Patient #2

This 15-year-old girl presented with anxiety problems and an ASD. Her early speech and motor development were normal. She had severe constipation from infancy onward. Rectal suction biopsy was normal. She refused school frequently during primary education and developed several phobias. At 11, her anxiety worsened; she feared choking while eating or sleeping. The patient had difficulty communicating emotions and disliked changes to her routine. At 12, she was diagnosed with an ASD and mild dyspraxia; however, she had above-average academic ability. By 14, she was having panic attacks and complex partial seizures. EEGs showed no epileptic activity, but found sharpened waveforms over the left hemisphere. An MRI brain scan revealed extensive bilateral PH (Figure 1 [B]). The PH was near-contiguous and extended into the anterior, posterior, and temporal horns of both lateral ventricles. Her anxiety and impulsivity worsened toward the end of her secondary education. She found socializing with peers difficult. She was easily upset and occasionally physically aggressive toward her parents. Her anxiety worsened perimenstrually. She expressed suicidal ideas, scratched herself, and struck her head against a wall when frustrated. The patient was treated with fluoxetine, levetiracetam, and low-dose sodium picosulfate. FLNA sequencing demonstrated a previously observed de novo 2 base pair deletion c.7612–3delCT that predicted a frameshift and premature truncation of the protein (p.Leu2537Aspfs*16).

Patient #3

This 39-year-old woman presented with intellectual disability (ID) and an acute episode of psychosis. The patient had a maternal great-aunt with epilepsy. The patient was diagnosed with Duane syndrome in infancy. Her development was normal until age 5, when she had generalized tonic–clonic seizures (GTCS). Subsequently, she had concentration problems and was diagnosed with mild ID but remained in mainstream school. At 17, she experienced focal motor seizures involving her right arm. An MRI brain scan revealed multiple nodules of PH bilaterally, with prominent ventricles (Figure 1 [C]). The PH nodules were mainly in the bodies of both lateral ventricles, with some nodules seen in the right posterior horn. In adulthood, the patient lived with her parents, but was self-caring with minimal guidance. She complained of migraines, became anxious over minor problems, and had poor spatial-orientation skills. At age 37, she suddenly became withdrawn, distracted, and highly agitated. She was restless, disoriented, required help with dressing and personal hygiene, and needed to be led from place to place. The patient’s speech became quiet, incoherent, and demonstrated flight-of-ideas. She complained of hearing voices. The patient was initially too distracted to answer questions about her orientation in space or time. Her EEG was normal, and a repeat MRI brain scan was unchanged. Sequencing and dosage analysis of FLNA were both normal. The patient was treated with risperidone, and symptoms slowly improved. Antipsychotic medication was stopped 1 year after the onset of the psychotic episode.

Patient #4

This 22-year-old woman presented with intellectual disability (ID) and depression. The patient had a younger brother with bipolar disorder. She was born at 23 weeks and 4 days gestation and spent 4 months in neonatal intensive care. In childhood, she was diagnosed with mild ID, dyslexia, dyspraxia, and a mild right hemiparesis. She attended mainstream school, but had problems with attention, fine motor skills and reading. At 13, she began experiencing migraines, mood swings, and low self-esteem. At 15, she took an overdose of analgesics and was diagnosed with depression. She took several more overdoses in subsequent years. At 16, the patient began experiencing unresponsive episodes that were suspected to be focal seizures. She also had occasional generalized tonic–clonic seizures (GTCS). An MRI brain scan at age 18 revealed bilateral PH (Figure 1 [D]). Multiple nodules of PH were seen in the bodies of both lateral ventricles. A 24-hour EEG demonstrated episodes of left-hemisphere slowing suggestive of cerebral dysfunction, but no epileptic activity. She was treated with lamotrigine, pregabalin, and venlafaxine. At 22, the patient continued to have low mood, mood swings, and disturbed sleep. She developed mild psychotic features including irrational thoughts, paranoia, and visual and auditory hallucinations. Her karyotype in addition to sequencing and dosage analysis of FLNA revealed no abnormalities.

Discussion

Neuropsychiatric disease is an under-recognized complication of PH. Previous clinical reports of patients with PH have generally focused on other neurological consequences, such as seizures, dyslexia, and intellectual disability. In contrast, we have highlighted the serious impact of behavioral and psychiatric problems on the lives of some individuals with PH. We searched the literature and found a total of 20 other patients with PH and a range of psychiatric problems, predominantly reported as single cases (Table 1). Diagnoses included psychotic illness,1,6,1014 depression,7,15,16 anxiety,8,17 behavior problems,1821 attention-deficit hyperactivity disorder (ADHD),22 and autism.9 Although this spectrum of disorders is diverse, these reports suggest a link between PH and psychiatric disease. Age at onset of psychiatric symptoms ranged from childhood to late middle-age, with many patients presenting in adolescence or early adulthood. Including our four patients, there was a slight female preponderance (9M:15F). The extent of the PH varied from single nodules to bilateral contiguous deposits. At least 11 of the patients had additional MRI abnormalities, including ventricular enlargement, cerebellar abnormalities, schizencephalic clefts, and cortical dysplasias. Patients with significant additional MRI abnormalities tended to have greater intellectual impairment.
TABLE 1. Reported Patients With Periventricular Heterotopia and Neuropsychiatric Disease
Report (Reference)SexAge at Onset [Age at Report]Psychiatric SymptomsIntelligenceEpilepsyPHOther Brain FindingsGenetics
(6)M(20)SchizophreniaNormalNoU,1
(6)F[27]SchizophreniaNormalNoU,1
(11)F[17]Psychotic symptoms? NormalNoB,MCerebellar vermian cleft
(10)F18Schizoaffective disorderIQ: 63YesB,CBilateral frontal schizencephaly; ASP
(7)F53Major depressive disorderNormalAbnormal EEGB,MSmall subcortical heterotopic nodules; posterior polygyria.Karyotype normal
(20)M[46]“Bizarre” behaviorNormalNoU,2Enlarged ventricle
(22)M[8]ADHDNormalNoa
(22)M[17]ADHDNormalNoa
(14)F16Schizophrenia???
(19)M[27]Behavior disturbancesPsycho-motor retardationYesU,1Cerebellar vermis hypoplasia; ACC; FCD; schizencephaly
(15)F[29]Major depressionReading problemsYesB,near-CFLNA normal
(18)M[34]Postictal rage; obsessive-compulsiveSevere IDYesB,MDiffuse cerebral and cerebellar atrophy.Karyotype normal
(12)M21Psychotic disorder episodic violence? mild IDYesB,M
(1)F[20]Delirium, ? psychoticIQ: 69NoB,CFLNA mutation
(17)FAdolescentAnxiety, depression? NormalAbnormal EEGU,1
(8)F[26]Anxiety and panic attacksNormalYesB,CAsymmetry of hippocampus.
(13)M18SchizophreniaBorderlineYesB,MPM: multiple microscopic heterotopic nodules (frontal).22q11.2 deletion
(21)F8Agitation with self-aggressionSevere DDNoUASP; parietal schizencephaly.
(9)M[7]Autism?YesU,2PM: Subependymal nodular and flocculonodular dysplasia.
(16)F23Anxiety, somatization disorderNormalYesB,C
This reportF[22]Anxiety, ASD, behavior problemsIQ: 61? YesB,near-CFLNA mutation
This reportF11Anxiety, ASD, behavior problemsNormalYesB,near-CFLNA mutation
This reportF37Acute psychosisMild IDYesB,MProminent ventriclesFLNA normal
This reportF13Depression, psychotic featuresMild IDYesB,MFLNA normal
PH: periventricular heterotopias, U(nilateral) or B(ilateral), and number of nodules: 1, 2, M(any) or C(ontiguous).
ACC: agenesis of the corpus callosum; ADHD: attention-deficit hyperactivity disorder; ASD: autism spectrum disorder; ASP: absent septum pellucidum; DD: developmental delay; EEG: electroencephalography; FCD: frontal cortical dysplasia; ID: intellectual disability; NOS: not otherwise specified; PM: postmortem; ?: unknown/uncertain.
a
A single, unilateral nodule was found in one of these two subjects; the other subject’s findings were unreported.
Despite these case reports, robust epidemiological evidence linking PH and psychiatric or behavioral disturbance is lacking. One study, which assessed MRI brain scans from 55 individuals with schizophrenia and 75 controls, reported PH in only 1 patient, and none in controls.23 Similarly, a study of MRI brain scans from 85 children with ADHD and 95 healthy controls reported PH in 2 patients, but none in controls.22 It remains possible that the PH is an incidental finding in patients with common psychiatric or behavioral problems. Many of the reported patients had ID (10/24) and/or a history of epilepsy (15/24, including those with an abnormal EEG) which are risk factors for psychiatric disease.24,25 This makes it difficult to establish whether PH is causal, or whether the psychiatric problems were just nonspecific complications of ID and/or epilepsy. At least one of the previously reported patients had a clear temporal relationship between seizures and exacerbation of his behavior problems.18
In addition to PH, other forms of neuronal heterotopia have been reported in patients with neuropsychiatric disease. Subcortical gray-matter heterotopia has been found in patients with psychosis26 and bipolar disorder.27 A neuropathological study found subcortical, periventricular, hippocampal, and cerebellar heterotopias in autistic subjects, but not in age-matched controls.9 Subtle cytoarchitectural abnormalities have also been observed in the entorhinal cortex28,29 and neocortical white matter3032 of some patients with schizophrenia. These findings are particularly interesting in light of the emerging associations between genes involved in neuronal migration and phenotypes such as schizophrenia, autism, and dyslexia.3335 It is possible that some PH patients have additional cytoarchitectural abnormalities below the resolution of current scanning technology. This is illustrated by the patient with 22q11.2 deletion syndrome and PH who had multiple microscopic heterotopic nodules in the frontal lobes at postmortem.13
The results of FLNA analysis in our four PH patients suggest that neuropsychiatric disease is not specific to individuals with mutations at the FLNA locus. We were struck by the similar features of the two patients with FLNA mutations described in this report. These included anxiety, low mood, impaired social interactions, violent outbursts, self-harming, and perimenstrual exacerbation of symptoms. These shared features may be coincidental, but they raise the interesting possibility that FLNA mutation carriers with PH may be particularly prone to these problems. However, our four cases have been reported retrospectively, based on review of their clinical records. This makes it difficult to provide consistent or comprehensive psychiatric mental status examinations. Future work in this area would benefit from prospective collection of data and the use of formal diagnostic criteria, to see whether specific psychiatric disorders are consistently being diagnosed in PH patients. Only two previously reported PH patients with neuropsychiatric problems had FLNA testing: one with bilateral, near-contiguous PH and a history of depression, whose sequencing was negative,15 and a second with classical bilateral PH and episodes of delirium who had a confirmed splice site-mutation.1 The etiology of the PH was unreported in the majority of cases.
In conclusion, we have highlighted neuropsychiatric disease as a potential consequence of PH. Clinicians need to be alert to the possibility of patients with PH presenting with behavioral and psychiatric complications. Aspects of this relationship remain uncertain, particularly the prevalence of psychiatric morbidity in PH patients, and how behavioral features are influenced by the underlying genetic cause of the PH. In the future, prospective, longitudinal studies of patients with neuronal migration disorders, incorporating a systematic evaluation of their molecular etiology and structured psychological assessment, will be valuable in elucidating these issues.

References

1.
Parrini E, Ramazzotti A, Dobyns WB, et al.: Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations. Brain 2006; 129:1892–1906
2.
van Kogelenberg M, Ghedia S, McGillivray G, et al.: Periventricular heterotopia in common microdeletion syndromes. Molecular Syndromology 2010; 1:35–41
3.
Chang BS, Ly J, Appignani B, et al.: Reading impairment in the neuronal migration disorder of periventricular nodular heterotopia. Neurology 2005; 64:799–803
4.
Guerrini R, Carrozzo R: Epileptogenic brain malformations: clinical presentation, malformative patterns, and indications for genetic testing. Seizure 2001; 10:532–543; quiz 544–537
5.
Fox JW, Lamperti ED, Ekşioğlu YZ, et al.: Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron 1998; 21:1315–1325
6.
Nopoulos PC, Flaum M, Andreasen NC, et al.: Gray-matter heterotopias in schizophrenia. Psychiatry Res 1995; 61:11–14
7.
Maruyama Y, Onishi H, Miura T, et al.: A case of depressive disorder with neuronal heterotopia. Psychiatry Clin Neurosci 1998; 52:361–362
8.
Ünal A, Saygi S: Clinical features, EEG findings, and outcome in patients with bilateral periventricular nodular heterotopia and epilepsy. Turk J Med Sci 2007; 37:157–165
9.
Wegiel J, Kuchna I, Nowicki K, et al.: The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol 2010; 119:755–770
10.
Alexander RC, Patkar AA, Lapointe JS, et al.: Schizencephaly associated with psychosis. J Neurol Neurosurg Psychiatry 1997; 63:373–375
11.
Sener RN: Cerebellar vermian clefts disconnecting the hemispheres: a different entity unassociated with Joubert’s syndrome. Comput Med Imaging Graph 1997; 21:71–75
12.
Pridmore S, McInerney G, Rybak M, et al.: Psychotic disorder NOS with heterotopia. J Psychiatric Intensive Care 2006; 2:118–121
13.
Kiehl TR, Chow EW, Mikulis DJ, et al.: Neuropathologic features in adults with 22q11.2 deletion syndrome. Cereb Cortex 2009; 19:153–164
14.
Takuya U, Mikio H, Itaru M, et al.: A case of schizophrenia with gray-matter heterotopias. Fukushima Medical Journal 2003; 53:265–269
15.
Sheen VL, Basel-Vanagaite L, Goodman JR, et al.: Etiological heterogeneity of familial periventricular heterotopia and hydrocephalus. Brain Dev 2004; 26:326–334
16.
Kandemir M, Pelin Z, Küçükali CI, et al.: A case with bilateral periventricular nodular heterotopia diagnosed as depression. Turk Norol Derg 2010; 16:114–118
17.
Pop L, Popa I, Bacos IC, et al.: 15 year-old girl with paresthesia, headache, and abdominal pain. Jurnalul Pediatrului 2007; 10:32–35
18.
Yankovsky AE, Veilleux M, Dubeau F, et al.: Post-ictal rage and aggression: a video-EEG study. Epileptic Disord 2005; 7:143–147
19.
d’Orsi G, Tinuper P, Bisulli F, et al.: Clinical features and long-term outcome of epilepsy in periventricular nodular heterotopias: simple compared with plus forms. J Neurol Neurosurg Psychiatry 2004; 75:873–878
20.
Cho WH, Seidenwurm D, Barkovich AJ: Adult-onset neurologic dysfunction associated with cortical malformations. AJNR Am J Neuroradiol 1999; 20:1037–1043
21.
Lin J, Peruchi MM, Masruha MR, et al.: Self-aggression and congenital clubfoot: additional features to the septo-optic dysplasia complex. Arq Neuropsiquiatr 2009; 67(2A):299–301
22.
Nopoulos P, Berg S, Castellenos FX, et al.: Developmental brain anomalies in children with attention-deficit hyperactivity disorder. J Child Neurol 2000; 15:102–108
23.
Nopoulos P, Swayze V, Flaum M, et al.: Incidence of ectopic gray matter in patients with schizophrenia and healthy control subjects studied with MRI. J Neuropsychiatry Clin Neurosci 1998; 10:351–353
24.
Marcangelo MJ, Ovsiew F: Psychiatric aspects of epilepsy. Psychiatr Clin North Am 2007; 30:781–802
25.
Borthwick-Duffy SA: Epidemiology and prevalence of psychopathology in people with mental retardation. J Consult Clin Psychol 1994; 62:17–27
26.
Akanuma N, Saitoh O, Yoshikawa T, et al.: Interictal schizophrenia-like psychosis in a patient with double cortex syndrome. J Neuropsychiatry Clin Neurosci 2002; 14:210–213
27.
Bourgeois JA, Nisenbaum J, Drexler KG, et al.: A case of subcortical grey-matter heterotopia presenting as bipolar disorder. Compr Psychiatry 1992; 33:407–410
28.
Falkai P, Schneider-Axmann T, Honer WG: Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality. Biol Psychiatry 2000; 47:937–943
29.
Arnold SE, Hyman BT, Van Hoesen GW, et al.: Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991; 48:625–632
30.
Akbarian S, Kim JJ, Potkin SG, et al.: Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 1996; 53:425–436
31.
Kirkpatrick B, Conley RC, Kakoyannis A, et al.: Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: an unbiased cell-counting study. Synapse 1999; 34:95–102
32.
Yang Y, Fung SJ, Rothwell A, et al.: Increased interstitial white-matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia. Biol Psychiatry 2011; 69:63–70
33.
Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, et al.: Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci 2009; 32:485–495
34.
Peñagarikano O, Abrahams BS, Herman EI, et al.: Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 2011; 147:235–246
35.
Wang Y, Paramasivam M, Thomas A, et al.: DYX1C1 functions in neuronal migration in developing neocortex. Neuroscience 2006; 143:515–522

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 26 - 31
PubMed: 23487190

History

Received: 10 November 2011
Revision received: 17 April 2012
Accepted: 11 June 2012
Published online: 1 January 2013
Published in print: Winter 2013

Authors

Details

Andrew E. Fry, M.B., Ch.B., D.Phil.
From the Institute of Medical Genetics (Dr. Fry and Prof. Pilz), Dept. of Child Health (Dr. Gibbon), Welsh Epilepsy Unit (Dr. Hamandi), University Hospital of Wales, Cardiff, UK; Dept. of Psychological Medicine and Neurology, Cardiff University, Cardiff, UK (Prof. Kerr); Clinical Genetics Dept., Royal Devon & Exeter Hospital, Exeter, UK (Dr. Turnpenny); Neuroradiology Dept., Frenchay Hospital, Bristol, UK (Dr. Stoodley); and the Dept. of Paediatrics and Child Health, University of Otago, Dunedin, New Zealand (Prof. Robertson).
Michael P. Kerr, M.B., Ch.B., M.Phil.
From the Institute of Medical Genetics (Dr. Fry and Prof. Pilz), Dept. of Child Health (Dr. Gibbon), Welsh Epilepsy Unit (Dr. Hamandi), University Hospital of Wales, Cardiff, UK; Dept. of Psychological Medicine and Neurology, Cardiff University, Cardiff, UK (Prof. Kerr); Clinical Genetics Dept., Royal Devon & Exeter Hospital, Exeter, UK (Dr. Turnpenny); Neuroradiology Dept., Frenchay Hospital, Bristol, UK (Dr. Stoodley); and the Dept. of Paediatrics and Child Health, University of Otago, Dunedin, New Zealand (Prof. Robertson).
Frances Gibbon, M.B., Ch.B.
From the Institute of Medical Genetics (Dr. Fry and Prof. Pilz), Dept. of Child Health (Dr. Gibbon), Welsh Epilepsy Unit (Dr. Hamandi), University Hospital of Wales, Cardiff, UK; Dept. of Psychological Medicine and Neurology, Cardiff University, Cardiff, UK (Prof. Kerr); Clinical Genetics Dept., Royal Devon & Exeter Hospital, Exeter, UK (Dr. Turnpenny); Neuroradiology Dept., Frenchay Hospital, Bristol, UK (Dr. Stoodley); and the Dept. of Paediatrics and Child Health, University of Otago, Dunedin, New Zealand (Prof. Robertson).
Peter D. Turnpenny, M.B., Ch.B.
From the Institute of Medical Genetics (Dr. Fry and Prof. Pilz), Dept. of Child Health (Dr. Gibbon), Welsh Epilepsy Unit (Dr. Hamandi), University Hospital of Wales, Cardiff, UK; Dept. of Psychological Medicine and Neurology, Cardiff University, Cardiff, UK (Prof. Kerr); Clinical Genetics Dept., Royal Devon & Exeter Hospital, Exeter, UK (Dr. Turnpenny); Neuroradiology Dept., Frenchay Hospital, Bristol, UK (Dr. Stoodley); and the Dept. of Paediatrics and Child Health, University of Otago, Dunedin, New Zealand (Prof. Robertson).
Khalid Hamandi, M.B., B.S., Ph.D.
From the Institute of Medical Genetics (Dr. Fry and Prof. Pilz), Dept. of Child Health (Dr. Gibbon), Welsh Epilepsy Unit (Dr. Hamandi), University Hospital of Wales, Cardiff, UK; Dept. of Psychological Medicine and Neurology, Cardiff University, Cardiff, UK (Prof. Kerr); Clinical Genetics Dept., Royal Devon & Exeter Hospital, Exeter, UK (Dr. Turnpenny); Neuroradiology Dept., Frenchay Hospital, Bristol, UK (Dr. Stoodley); and the Dept. of Paediatrics and Child Health, University of Otago, Dunedin, New Zealand (Prof. Robertson).
Neil Stoodley, B.M., B.Ch.
From the Institute of Medical Genetics (Dr. Fry and Prof. Pilz), Dept. of Child Health (Dr. Gibbon), Welsh Epilepsy Unit (Dr. Hamandi), University Hospital of Wales, Cardiff, UK; Dept. of Psychological Medicine and Neurology, Cardiff University, Cardiff, UK (Prof. Kerr); Clinical Genetics Dept., Royal Devon & Exeter Hospital, Exeter, UK (Dr. Turnpenny); Neuroradiology Dept., Frenchay Hospital, Bristol, UK (Dr. Stoodley); and the Dept. of Paediatrics and Child Health, University of Otago, Dunedin, New Zealand (Prof. Robertson).
Stephen P. Robertson, M.B., Ch.B., D.Phil.
From the Institute of Medical Genetics (Dr. Fry and Prof. Pilz), Dept. of Child Health (Dr. Gibbon), Welsh Epilepsy Unit (Dr. Hamandi), University Hospital of Wales, Cardiff, UK; Dept. of Psychological Medicine and Neurology, Cardiff University, Cardiff, UK (Prof. Kerr); Clinical Genetics Dept., Royal Devon & Exeter Hospital, Exeter, UK (Dr. Turnpenny); Neuroradiology Dept., Frenchay Hospital, Bristol, UK (Dr. Stoodley); and the Dept. of Paediatrics and Child Health, University of Otago, Dunedin, New Zealand (Prof. Robertson).
Daniela T. Pilz, M.D.
From the Institute of Medical Genetics (Dr. Fry and Prof. Pilz), Dept. of Child Health (Dr. Gibbon), Welsh Epilepsy Unit (Dr. Hamandi), University Hospital of Wales, Cardiff, UK; Dept. of Psychological Medicine and Neurology, Cardiff University, Cardiff, UK (Prof. Kerr); Clinical Genetics Dept., Royal Devon & Exeter Hospital, Exeter, UK (Dr. Turnpenny); Neuroradiology Dept., Frenchay Hospital, Bristol, UK (Dr. Stoodley); and the Dept. of Paediatrics and Child Health, University of Otago, Dunedin, New Zealand (Prof. Robertson).

Notes

Address correspondence to Dr Andrew E. Fry, Institute of Medical Genetics, University Hospital of Wales, Cardiff, Wales; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share